Ajanta Pharma Limited - Company Profile

Q: Who are the current directors of Ajanta Pharma Limited?

The current directors of Ajanta Pharma Limited are David Paul Rasquinha, Simi Manohar Lal Thapar, Rajesh Shashikant Dalal, Madhusudan Bhagwandas Agrawal, Gaurang Chinubhai Shah, Medha Vinay Joshi, Mannalal Bhagwandas Agrawal, Rajesh Mannalal Agrawal, Yogesh Mannalal Agrawal, Arvind Kanhaiyalal Agrawal.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1979.

1979 Mumbai, Maharashtra, India Active

Last Updated: January 28, 2026

Access Report

About Ajanta Pharma Limited

Ajanta Pharma Limited, a active public limited company, was established on 31 December 1979 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230MH1979PLC022059. Registered under ROC Roc Mumbai. it is listed on BSE: 532331 and NSE: AJANTPHARM. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹24.99 Cr.

Formerly known as Ajanta Pharma Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹4,087.60 Cr and a net worth of ₹3,413.57 Cr. Employing 7,869 professional, Its leadership includes David Paul Rasquinha (Director), Simi Manohar Lal Thapar (Director), Rajesh Shashikant Dalal (Director). Past directors included Napoleon Chelliah, Chandrakant Mohanlal Khetan, Manjiri Manohar Bhalerao. It holds ₹65.00 Cr open charges and ₹548.84 Cr settled loans. Its latest AGM occurred on 17 July 2025, with the balance sheet filed on 31 March 2025. It is based at Ajanta Tower, 54-A, M Vasanji Road,, Chakala, Andheri (E),, Mumbai, Maharashtra, 400093.

Company Details

CIN/LLPIN
L24230MH1979PLC022059
Registration Number
022059
Incorporation Date
31 December 1979
Authorized Capital
₹30.00 Cr
Paid-Up Capital
₹24.99 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 532331, NSE: AJANTPHARM)
Company Status
Active

Key Metrics

Authorised Capital ₹ 30.00 Cr as on 28-01-2026
Paid Up Capital ₹ 24.99 Cr as on 28-01-2026
Company Age 46 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 65.00 Cr as on 28-01-2026
Satisfied Charges ₹ 548.84 Cr as on 28-01-2026
Revenue Growth **** 8.67% (FY 2025)
Profit Growth **** 13.58% (FY 2025)
Ebitda **** 7.62% (FY 2025)
Net Worth 6.20% (FY 2025)
Total Assets **** 7.99% (FY 2025)

Comprehensive Company Insights

Explore comprehensive insights into Ajanta Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Ajanta Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
David Paul Rasquinha	Director	02 May 2024	Current
Simi Manohar Lal Thapar	Director	02 May 2024	Current
Rajesh Shashikant Dalal	Director	02 May 2024	Current
Madhusudan Bhagwandas Agrawal	Whole-Time Director	31 Dec 1979	Current
Medha Vinay Joshi	Director	02 May 2024	Current
Mannalal Bhagwandas Agrawal	Director	31 Dec 1979	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Company Secretary	17 Jan 2009	Past
Pramod Abcsdd	Director	17 Jul 2019	Past
Pramod Abcsdd	Nominee Director	30 Apr 2011	Past
Pramod Abcsdd	Director	17 Jul 2019	Past
Pramod Abcsdd	Additional Director	17 Jul 2024	Past
Pramod Abcsdd	Additional Director	17 Jul 2024	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ajanta Pharma.

Ajanta Pharma Limited, for the financial year ended 2025, experienced modest growth in revenue, with a 8.67% increase. The company also saw a substantial improvement in profitability, with a 13.58% increase in profit. The company's net worth moved up by a moderate rise of 6.2%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

8.67%

*******

Revenue from Operations

*******

8.84%

*******

Total Assets

*******

7.99%

*******

Profit or Loss

*******

13.58%

*******

Net Worth

*******

6.20%

*******

EBITDA

*******

7.62%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ajanta Pharma?

In 2024, Ajanta Pharma had a promoter holding of 66.22% and a public holding of 33.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹650,000,000.00

Satisfied Charges

₹5,488,389,073.00

Charges Breakdown by Lending Institutions

Citi Bank N.A. : 35.00 Cr
Others : 20.00 Cr
Idbi Bank Limited : 10.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
25 Jan 2024	Idbi Bank Limited	₹10.00 Cr	Open
11 Feb 2021	Others	₹10.00 Cr	Open
26 Jun 2020	Citi Bank N.A.	₹35.00 Cr	Open
03 Jul 1997	Others	₹10.00 Cr	Open
21 Mar 2013	State Bank Of Mauritius Limited	₹55.16 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ajanta Pharma?

Ajanta Pharma has a workforce of 7869 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ajanta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajanta Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ajanta Pharma

Recent Activity within the Organization

Annual General Meeting

Progress on Ajanta Pharma Limited last Annual general meeting of members was held on 17 Jul 2025 as per latest MCA records. was documented.
17 Jul 2025
Balance Sheet

Ajanta Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

The activity David Paul Rasquinha was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 9 months . was completed.
02 May 2024
Director Appointment

Simi Manohar Lal Thapar was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
02 May 2024
Director Appointment

Rajesh Shashikant Dalal was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
02 May 2024
Director Appointment

Progress on Medha Vinay Joshi was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 9 months . was documented.
02 May 2024

Explore recent activity and updates - View Recent Activity